HS, F., RBAR, d. M., E, B., LCA, B., OR, G., JLML, M., . . . Y, S. (2025). P2Y12 inhibitors plus aspirin versus aspirin alone in patients with ischemic cerebrovascular events: An updated meta-analysis of randomized controlled trials. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 34(2), 108180. https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108180
Chicago Style (17th ed.) CitationHS, Faria, et al. "P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients with Ischemic Cerebrovascular Events: An Updated Meta-analysis of Randomized Controlled Trials." Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association 34, no. 2 (2025): 108180. https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108180.
MLA (9th ed.) CitationHS, Faria, et al. "P2Y12 Inhibitors Plus Aspirin Versus Aspirin Alone in Patients with Ischemic Cerebrovascular Events: An Updated Meta-analysis of Randomized Controlled Trials." Journal of Stroke and Cerebrovascular Diseases : The Official Journal of National Stroke Association, vol. 34, no. 2, 2025, p. 108180, https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.108180.